TR201103752A2 - Combinations of thiocolchicoside, diclofenac and lansoprazole. - Google Patents

Combinations of thiocolchicoside, diclofenac and lansoprazole.

Info

Publication number
TR201103752A2
TR201103752A2 TR2011/03752A TR201103752A TR201103752A2 TR 201103752 A2 TR201103752 A2 TR 201103752A2 TR 2011/03752 A TR2011/03752 A TR 2011/03752A TR 201103752 A TR201103752 A TR 201103752A TR 201103752 A2 TR201103752 A2 TR 201103752A2
Authority
TR
Turkey
Prior art keywords
thiocolchicoside
lansoprazole
diclofenac
combinations
pharmaceutically acceptable
Prior art date
Application number
TR2011/03752A
Other languages
Turkish (tr)
Inventor
Mustafa İskender Pi̇sak İbrahi̇m
Bi̇ngöl Semra
Levent Selamoğlu Mehmet
Original Assignee
Ak Ki̇mya İthalat-İhracat Ve Sanayi̇i̇ A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ak Ki̇mya İthalat-İhracat Ve Sanayi̇i̇ A.Ş. filed Critical Ak Ki̇mya İthalat-İhracat Ve Sanayi̇i̇ A.Ş.
Priority to TR2011/03752A priority Critical patent/TR201103752A2/en
Priority to PCT/TR2012/000060 priority patent/WO2012144964A1/en
Publication of TR201103752A2 publication Critical patent/TR201103752A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş; kas gevşetici olarak tiyokolşikozit ya da farmasötik olarak kabul edilebilir bir tuzunu, non-steroidal anti-enflamatuar ilaç olarak diklofenak ya da farmasötik olarak kabul edilebilir bir tuzunu; ve mide koruyucu ilaç olarak lansoprazol ya da farmasötik olarak kabul edilebilir bir tuzunu içeren birim dozaj formlarına ilişkindir.The present invention includes; a thiocolchicoside or a pharmaceutically acceptable salt thereof as a muscle relaxant; diclofenac as a non-steroidal anti-inflammatory drug or a pharmaceutically acceptable salt thereof; and lansoprazole or a pharmaceutically acceptable salt thereof as a gastric preservative.

TR2011/03752A 2011-04-18 2011-04-18 Combinations of thiocolchicoside, diclofenac and lansoprazole. TR201103752A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2011/03752A TR201103752A2 (en) 2011-04-18 2011-04-18 Combinations of thiocolchicoside, diclofenac and lansoprazole.
PCT/TR2012/000060 WO2012144964A1 (en) 2011-04-18 2012-04-18 Thiocolchicoside, diclofenac and lansoprazole combinations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2011/03752A TR201103752A2 (en) 2011-04-18 2011-04-18 Combinations of thiocolchicoside, diclofenac and lansoprazole.

Publications (1)

Publication Number Publication Date
TR201103752A2 true TR201103752A2 (en) 2012-11-21

Family

ID=46246160

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/03752A TR201103752A2 (en) 2011-04-18 2011-04-18 Combinations of thiocolchicoside, diclofenac and lansoprazole.

Country Status (2)

Country Link
TR (1) TR201103752A2 (en)
WO (1) WO2012144964A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2848260T3 (en) * 2013-09-12 2016-09-30 Novel formulations of thiocolchicoside
EP2848261B1 (en) * 2013-09-12 2016-04-20 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical formulations comprising a muscle relaxant and an analgesic combination
ES2577118T3 (en) * 2013-09-12 2016-07-13 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical formulations for sustained release of thiocolchicose
EP3160507A1 (en) * 2014-06-30 2017-05-03 Sanovel Ilac Sanayi ve Ticaret A.S. Loxoprofen and gamma-aminobutiric acid receptor agonist combinations
WO2016102661A1 (en) * 2014-12-23 2016-06-30 Krka, D.D., Novo Mesto Pharmaceutical tablet composition
WO2017084680A1 (en) * 2015-11-17 2017-05-26 Rontis Hellas S.A. Pharmaceutical composition containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
TR201717134A2 (en) * 2016-12-07 2018-07-23 Imuneks Farma Ilac Sanayi Ve Ticaret Anonim Sirketi Rapid Release Oral Combinations of Diclofenac and H2 Receptor Antagonists for Rapid Treatment of Pain and Inflammation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2725134B1 (en) 1994-10-04 1996-12-20 Lederle Lab NEW PHARMACEUTICAL ASSOCIATION BASED ON IBUPROFEN AND THIOCOLCHICOSIDE
FR2735369B1 (en) * 1995-06-13 1997-07-11 Synthelabo PHARMACEUTICAL COMPOSITIONS BASED ON SODIUM SALT OF DICLOFENAC AND THIOCOLCHICOSIDE
SE9600070D0 (en) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
AU7916798A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
US6544556B1 (en) * 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
ATE474559T1 (en) 2001-06-01 2010-08-15 Pozen Inc PHARMACEUTICAL COMPOSITIONS FOR COORDINATED DELIVERY OF NSAIDS
US20050163847A1 (en) * 2004-01-21 2005-07-28 Andrx Pharmaceuticals, Llc Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug
EP1718303A4 (en) 2004-02-10 2010-09-01 Santarus Inc Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
US20100297224A1 (en) * 2006-08-31 2010-11-25 Horizon Therapeutics, Inc. NSAID Dose Unit Formulations with H2-Receptor Antagonists and Methods of Use
TR200703092A1 (en) 2007-05-08 2008-12-22 SANOVEL �LA� SAN. VE TiC. A.�. Flurbiprofen and muscle relaxant combinations
FR2926723B1 (en) * 2008-01-25 2010-06-18 Duo Ge ORAL PHARMACEUTICAL ASSOCIATIONS.
US20090233970A1 (en) 2008-03-11 2009-09-17 Nickell Robert P Combined nsaid and acid blocker formulation and method
UA102010C2 (en) 2009-01-22 2013-05-27 Санофі Combination of active ingredients comprising a non steroidal anti inflammatory drug and a colchicoside derivative

Also Published As

Publication number Publication date
WO2012144964A1 (en) 2012-10-26

Similar Documents

Publication Publication Date Title
CY1120480T1 (en) PYRAZOLOPYRIMIDINE COMPOUNDS
CY1121625T1 (en) PRMT5 INHIBITORS AND USES THEREOF
TR201103752A2 (en) Combinations of thiocolchicoside, diclofenac and lansoprazole.
CY1119167T1 (en) SUSPENSIONS TOY NKCC FOR TREATMENT OF AUTISM
CY1119798T1 (en) FORM IV IV Hydrochloride Ibabradine
CY1116645T1 (en) NOTCH-SUSPENSION SIGNAL PATH
EA201390908A1 (en) DERIVATIVES OF BICYCLO [3.2.1] OCTYLAMIDE AND THEIR APPLICATION
EA201201263A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DAGIGATRAN ETEXYLATE
RS54873B1 (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
BR112012026767A2 (en) compound, pharmaceutically acceptable salt of a compound, pharmaceutical composition, method for treating or preventing disorders, and use of a compound or salt
EA201490949A1 (en) KINAZ INHIBITORS
EA201391615A1 (en) DATED POTENTIATORS CFTR
EA201692167A1 (en) MODULATORS OF TOLL-SECONDARY RECEPTORS
EA201070786A1 (en) BENZOFUROPYRIMIDINONES
MY163083A (en) Solid forms of a pharmaceutically active substance
EA201390804A1 (en) DOSAGE FORM LACOSAMIDE FOR ADMISSION ONCE IN DAY
BR112014010631A2 (en) pak inhibitors for the treatment of fragile x syndrome
CY1124331T1 (en) INCREASED BIOAVAILABILITY OF ACTIVE SUBSTANCE IN NALTREXONE THERAPY
EA201001710A2 (en) PHARMACEUTICAL COMPOSITION, WHICH CONTAINS SALT STRONTIUM, VITAMIN D AND CYCLODEXTRIN
CY1121999T1 (en) PHARMACEUTICAL FORMS OF DARUNAVIR COMBINATION
EA201492287A1 (en) DEUTERED DERIVATIVES RUXOLITINIBA
EA201390428A1 (en) COMPOSITIONS AND METHODS OF TREATMENT OF PULMONARY HYPERTENSION
EA201490761A1 (en) R (+) - N-Formylpropylglycinone
EA201390539A1 (en) HETEROARILES AND THEIR APPLICATION
EA201491658A1 (en) TABLETS FOR COMBINED THERAPY